Author: ollipulkka
The Board of Directors of Sartar Therapeutics has appointed Katja Ivanitskiy as the new CEO of Sartar Therapeutics as of 9 November 2020.
Sartar warmly welcomes Katja to the company!
Sartar has been selected as one of only six finalists at the NOME Startup Competition 2020, November 18.
Sartar was selected among close to 100 other companies who also applied to the competition.
Successful investment round!
Sartar’s investment round closed ahead of time on Monday (19.10.2020). We achieved incredible outcome of 2 300 000 euros just in six days.
Sartar wishes to thank all investors for taking part in the round. We would also like to thank Springvest, for helping us to achieve this goal. Thank you!
Sartarin rahoituskierros on auki!
Sartar on avannut rahoituskierroksen yhdessä Springvestin kanssa! Rahoituskierros on auki lokakuun loppuun asti. Osoitteesta https://app.springvest.fi/rounds/144 löytyy lisätietoa kampanjasta!
